ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,339,000 | -92.0% | 28,900 | -95.8% | 0.05% | -91.9% |
| Q1 2019 | $16,728,000 | +166.3% | 686,100 | +55.6% | 0.58% | +140.1% |
| Q4 2018 | $6,282,000 | -22.3% | 440,800 | -17.1% | 0.24% | -32.6% |
| Q3 2018 | $8,082,000 | +60.8% | 531,700 | +77.5% | 0.36% | +31.5% |
| Q2 2018 | $5,026,000 | +145.8% | 299,500 | +139.0% | 0.27% | +78.4% |
| Q1 2018 | $2,045,000 | +1485.3% | 125,312 | +1146.3% | 0.15% | +1290.9% |
| Q4 2017 | $129,000 | -84.2% | 10,055 | -91.7% | 0.01% | -92.1% |
| Q3 2016 | $819,000 | – | 121,309 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |